Integrated Campaign
Eversense 365
We're navigating a challenger brand break through a billion-dollar category with a data-driven, integrated approach.
Background
Nearly 15% of U.S. adults live with diabetes and rely on continuous glucose monitors (CGM) for daily safety and health management. Historically, this market was limited to short-term devices that required patients to perform self-insertions up to every two weeks. Eversense redefined the category by introducing the world's first and only long-term CGM system with an implanted sensor. Their latest innovation, Eversense 365, is designed to last a full year, eliminating the burden of 24–36 sensor changes annually. This medical technology offers patients a more flexible, less constrained life while providing healthcare providers with a more reliable data tool.
The Challenge
Traditional CGMs have to be replaced every other week, require upkeep and can leave painful marks. Eversense 365 is the only CGM that lasts a year, offering a revolutionary 365-day sensor placed inside the arm. Despite this innovation, Eversense faced extremely low awareness among patients and providers in a market dominated by Dexcom and Freestyle Libre.
Our Approach
Differentiate Eversense 365 in a big budget, highly competitive category and drive qualified leads. Our integrated "One Year, One CGM" campaign balances the functional innovation of the brand with the emotional reassurance of living your life uninterrupted.
Results
Our end-to-end performance engine integrates website strategy, creative intelligence, and algorithmic investment strategies to drive real business results: 37% increase in qualified leads, 25% lift in brand awareness during the launch quarter, and >2x growth in qualified leads.
Explainer Series
This video series introduces Eversense 365, the world’s first fully implantable CGM system that provides accurate glucose monitoring for an entire year through a single, minimally invasive procedure. Hosted by George, the episodes explore the advanced science behind the long-lasting sensor and the simple, stitch-free office visit required for placement.
What You Need To Know
George introduces Eversense 365, the first and only fully implantable one-year continuous glucose monitoring (CGM) system designed to manage diabetes with minimal device disruption.Science and Technology
Advanced science and technology that enables Eversense 365 to provide reliable glucose readings for a year with a single under-the-skin sensor.Quick and Easy Procedure
Eversense 365 sensor placement is a quick, minimally invasive office procedure performed by a healthcare provider that allows for a full year of continuous glucose monitoring without the need for stitches.Social Performance Engine
Engineering & Innovation
Exploded View
A detailed look at what makes Eversense 365 unlike anything else in the category. This animated exploded view breaks down the implantable sensor’s components, translating complex medical technology into a clear, compelling visual that builds confidence with both patients and providers.
Patient Consumer Website
A detailed look at what makes Eversense 365 unlike anything else in the category. This animated exploded view breaks down the implantable sensor’s components, translating complex medical technology into a clear, compelling visual that builds confidence with both patients and providers.
